Glenmark Pharmaceuticals' Finacea generic infringes Bayer patent: court

NEW YORK (Reuters) - India's Glenmark Pharmaceuticals' proposed generic version of Bayer AG's Finacea, a gel for treating the common skin condition rosacea, infringes Bayer's patent, a U.S. court ruled on Monday.

Source: Reuters: Health - July 27, 2015 Category: Consumer Health News Tags: healthNews Source Type: news